Judge Certifies Pay-For-Delay Insurer Class For Alzheimer’s Drug Namenda, Generics
Mealey's (February 16, 2021, 1:14 PM EST) -- NEW YORK — A New York federal judge on Feb. 11 granted a motion by a union health benefit fund to certify a class of purchasers of the Alzheimer’s drug Namenda...
To view the full article, register now.
Try for FREE for fourteen days
Already a subscriber? Click here to login